Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: INTEGRATED DNA TECHNOLOGIES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-04-18 to 2022-09-30
Current total value of award: $102912
Description: CUSTOM SYNTHESIS OF 1536 ANTISENSE OLIGONUCLEOTIDES FOR SARS-COV2 PROJECT